A Phase 1b Study of a Q-Griffithsin Intranasal Spray for Broad-spectrum Coronavirus Prophylaxis
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of multiple doses of a Q-GRFT nasal spray in
healthy volunteers. This Q-GRFT nasal spray is "investigational and not approved by the FDA
for general use" and is being developed to prevent the transmission of COVID-19 and other
coronaviruses.